Completion of parameters of the physical admission process, as percentages and fraction of total number of cases for which each parameter was applicable, at baseline, PDSA 1, 2 and reaudit
| Baseline (n=139) | PDSA cycle 1 (n=40) | PDSA cycle 2 (n=20) | Reaudit (n=20) | |
| General screen* | 74.1% (103/139) | 87.5% (35/40) | 75% (15/20) | 60% (12/20) |
| Body map† | 55.4% (77/139) | 62.5% (25/40) | 85% (17/20) | 80% (16/20) |
| Venous thromboembolism assessment | 70.5% (98/139) | 80% (32/40) | 80% (16/20) | 85% (17/20) |
| Full physical health screen‡ | 74.8% (104/139) | 80% (20/25 pre doctor change over) 60% (9/15 post doctor change over) | 90% (18/20) | 90% (18/20) |
| Use of a chaperone | 56.1% (78/139) | 55% (22/40) | 50% (10/20) | 70% (14/20) |
| Baseline blood tests§ | 79.1% (110/139) | 77.5% (31/40) | 85% (17/20) | 75% (15/20) |
| Plan for reattempts if incomplete | 25.7% (9/35) | 45.5% (5/11) | 50% (2/4) | 50% (1/2) |
| Capacity assessment in patients refusing | 19.0% (4/21) | 80% (8/10) | 100% (1/1) | 0% (0/0) |
| ECG completed | 64.7% (90/139) | 67.5% (27/40) | 85% (17/20) | 90% (18/20) |
*This includes a general physical observation of the patient (eg, mobility, alertness, overall wellness), measurement of physical observations if available and documentation of their past medical history and allergy status.
†Identifying body scars, bruises, piercings and tattoos.
‡Detailed physical examination of patient including cardiovascular, respiratory, abdominal and neurological examinations.
§Full blood count, urea and electrolytes, liver function tests, thyroid function, C reactive protein, B12, folate, bone profile, prolactin, cholesterol, HBA1c.
PDSA, plan do study act.